子宫切除术后并发症:新型与传统血红蛋白A1c切点比较
回顾性队列分析Cerner Health Facts数据库中2010年1月至2018年11月接受子宫切除术且有围术期HbA1c值的患者,比较HbA1c>8.0%与>8.85%切点与术后并发症复合终点的关联。HbA1c作为连续变量及两个切点均与更多并发症相关,HbA1c>8.85%的多变量OR=1.71(95%CI=1.25-2.32)。作者认为8.0%和8.85%均为可接受的切点,多变量模型优于单用HbA1c,需进一步研究。
要点
- HbA1c作为连续变量与子宫切除术后并发症增多相关(p=.03)。
- HbA1c>8.0%(p=.01)和>8.85%(p=.001)均与更多并发症相关。
- 多变量分析中HbA1c>8.85%增加并发症(OR=1.71,95%CI=1.25-2.32)。
核心结论
- HbA1c作为连续变量影响并发症,因此降低HbA1c可能减少并发症。
- 对于根据术前HbA1c决定是否进行子宫切除术的外科医生,8.0%和8.85%均为可接受的切点。
- 多变量模型优于单用HbA1c,需进一步研究以预测并发症。
研究设计与样本
- 纳入2010年1月至2018年11月接受腹腔镜±机器人辅助、经阴道或经腹子宫切除术且有围术期HbA1c值的患者,包括已诊断糖尿病或接受筛查者。
- 采用单变量和多变量逻辑回归,结局为任何术后并发症的复合终点。
- HbA1c作为连续变量和分类变量(切点>8.0%基于指南,>8.85%基于当前数据集的受试者工作特征分析)进行调整。
- 86,420例子宫切除术中,2,693例(3.1%)有未排除的HbA1c值,其中514例(19.1%)有并发症,2,179例(80.9%)无并发症。
主要发现
- 并发症中位时间为18天。
- 患者75.2%为白人,83.2%来自城市医院;手术路径以微创为主:30.5%腹腔镜、25.6%经阴道、43.9%经腹,69.8%切除附件。
- 有并发症者更年长(60.5±15.9岁 vs 58.4±14.2岁,p=.004),更多来自美国南部(24.5% vs 18.5%,p=.006),更多吸烟(26.7% vs 19.0%,p<.001),更多肥胖(32.3% vs 23.3%,p<.001)。
- 大多数并发症为感染性(87.4%)。
- HbA1c>8.85%优化检验特征:敏感度=0.14,特异度=0.91,PPV=0.27,NPV=0.82。
关键数值与推荐
- HbA1c>8.0%基于指南作为切点。
- HbA1c>8.85%基于当前数据集的受试者工作特征分析作为切点。
- HbA1c>8.85%的敏感度=0.14,特异度=0.91,PPV=0.27,NPV=0.82。
临床怎么用
- 对于根据术前HbA1c决定是否进行子宫切除术的外科医生,8.0%和8.85%均为可接受的切点。
- 多变量模型优于单用HbA1c,需进一步研究以预测并发症。
局限性
- 需进一步研究以预测并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To investigate the correlation between HbA1c and complications after hysterectomies. DESIGN: Retrospective cohort analysis. SETTING: Cerner Health Facts (519 million patient encounters from 750 hospitals). PATIENTS: Patients undergoing laparoscopic ± robotic-assisted, vaginal, or abdominal hysterectomy, January 2010 to November 2018. We included patients with perioperative HbA1c values, including those diagnosed with diabetes or undergoing screening. INTERVENTIONS: We performed univariable and multivariable logistic regressions with the outcome a composite of any post-op complication. We adjusted for HbA1c as continuous and categorical variables using HbA1c (>8.0% based on guidelines and >8.85% based on receiver operating characteristic analysis from current dataset) as cut-points. MEASUREMENTS AND MAIN RESULTS: Of 86,420 hysterectomies, 2693 (3.1%) had nonexcluded HbA1c, including 514 (19.1%) with complications and 2179 (80.9%) without. Median time to complication was 18 days. Patients were 75.2% white, 83.2% in urban hospitals. Route was predominantly minimally invasive: 30.5% laparoscopic, 25.6% vaginal, 43.9% abdominal, with 69.8% adnexa removed. Patients with complications were older (60.5 ± 15.9 vs 58.4 ± 14.2 years, p = .004), more likely from the Southern US (24.5% vs 18.5%, p = .006), used tobacco (26.7% vs 19.0%, p < .001), and were obese (32.3% vs 23.3%, p < .001). Most complications were infectious (87.4%). Higher HbA1c was associated with more complications, whether continuous (p = .03), HbA1c > 8.0% (p = .01), or HbA1c > 8.85% (p = .001). HbA1c > 8.85% optimized test characteristics (sensitivity = 0.14, specificity = 0.91, PPV = 0.27, NPV = 0.82). Predictive value improved with confounders (area under the curve = 0.71-0.72), and multivariable analysis demonstrated HbA1c > 8.85% increased complications (odds ratio [OR] = 1.71, 95% CI = 1.25-2.32). Obesity (OR = 1.31, 95% CI = 1.04-1.64) and urogynecological diagnoses, including urinary frequency, history of urinary tract infection, and dysuria (OR = 2.31, 3.71, 3.98, respectively), also increased complications. CONCLUSION: HbA1c as a continuous variable impacted complications, so HbA1c reductions will likely decrease complications. For surgeons deciding to proceed with hysterectomy based on preoperative HbA1c, 8.0% and 8.85% are both acceptable cut-points. Multivariable models outperformed HbA1c alone, warranting further research to predict complications.
引用
- Matese N, Wang X, Sahil S, et al. Postoperative Hysterectomy Complications: Comparing Novel Versus Traditional Hemoglobin A1c Cut-Offs. J Minim Invasive Gynecol. 2025. PMID: 41319899. doi:10.1016/j.jmig.2025.11.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。